Here are four highlights:
1. The company’s notes have a 3.65 percent annual interest rate.
2. Stryker’s offering is expected to settle March 7, subject to customary closing conditions.
3. Stryker plans to use the proceeds to repay $600 million of the company’s previous 1.30 percent notes due April 1.
4. Goldman Sachs & Co., Morgan Stanley and Wells Fargo are active joint book running managers for Stryker’s offering.
More articles on devices and implants:
Where Medtronic is headed: 5 quotes from the Q3 conference call
K2M, International Spine Study Group Foundation join forces for spine data collection – 5 things to know
Who’s leading the global spine surgery device market?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
